CureVac Is Promised Up to $298 Million for Coronavirus Vaccine Development by Germany
Germany-based biotech CureVac (NASDAQ: CVAC) announced on Friday it has been pledged a large chunk of grant money to help develop its coronavirus vaccine candidate. The company said the German government's Federal Ministry of Education and Research notified it that up to 252 million euros ($298 million) will be provided.
CureVac applied for the grant in July, as part of a government initiative to speed along vaccine candidates. Later that month, the company was announced as one of a group of successful applicants.
Image source: Getty Images.
Source Fool.com
